Financials

  • Market Capitalization 113.43 M
  • Employee 152
  • Founded 2013
  • CEO N/A
  • Website www.lenz-tx.com
  • Headquarter Delaware, United States
  • FIGI BBG00XDH4NZ2
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.61
Rapporto prezzo/fatturato
24.15

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3803
ENGN
enGene Therapeutics Inc. - Common Stock
1.70 USD-1.73%-9.09%-5.56%-79.76%113.93 M USD
3804
TNXP
Tonix Pharmaceuticals Holding Corp. - Common Stock
6.64 USD-9.04%-18.53%-43.63%-55.76%113.88 M USD
3810
CBUS
Cibus, Inc. - Class A Common Stock
1.43 USD-3.38%-12.27%-8.92%-2.05%109.29 M USD
3812
COYA
Coya Therapeutics, Inc. - Common Stock
4.71 USD-2.08%-3.88%+7.29%-20.44%110.49 M USD